193 related articles for article (PubMed ID: 32628915)
1. Levodopa Positively Affects Neovascular Age-Related Macular Degeneration.
Figueroa AG; Boyd BM; Christensen CA; Javid CG; McKay BS; Fagan TC; Snyder RW
Am J Med; 2021 Jan; 134(1):122-128.e3. PubMed ID: 32628915
[TBL] [Abstract][Full Text] [Related]
2. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
3. Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration.
Li E; Donati S; Lindsley KB; Krzystolik MG; Virgili G
Cochrane Database Syst Rev; 2020 May; 5(5):CD012208. PubMed ID: 32374423
[TBL] [Abstract][Full Text] [Related]
4. Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration.
Brilliant MH; Vaziri K; Connor TB; Schwartz SG; Carroll JJ; McCarty CA; Schrodi SJ; Hebbring SJ; Kishor KS; Flynn HW; Moshfeghi AA; Moshfeghi DM; Fini ME; McKay BS
Am J Med; 2016 Mar; 129(3):292-8. PubMed ID: 26524704
[TBL] [Abstract][Full Text] [Related]
5. Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration.
Sridhar J; Hsu J; Shahlaee A; Garg SJ; Spirn MJ; Fineman MS; Vander J
JAMA Ophthalmol; 2016 Apr; 134(4):437-43. PubMed ID: 26914218
[TBL] [Abstract][Full Text] [Related]
6. Anti-VEGF Treatment Strategies for 3 Subtypes of Neovascular Age-Related Macular Degeneration in a Clinical Setting: A Multicenter Cohort Study in Japan.
Yoneda K; Takeuchi M; Yasukawa T; Terasaki H; Yamamoto Y; Jujo T; Wakuta M; Matsubara H; Mitamura Y; Kato A; Kondo M; Kimura K; Takagi H; Gomi F; Sakamoto T;
Ophthalmol Retina; 2023 Oct; 7(10):869-878. PubMed ID: 37295608
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept.
Sato T; Enoki T; Karasawa Y; Someya H; Taguchi M; Harimoto K; Takayama K; Kanda T; Ito M; Takeuchi M
Front Immunol; 2021; 12():738521. PubMed ID: 34721402
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone implant prior to anti-VEGF therapy in pigment epithelium detachments with high-risk rupture characteristics secondary to neovascular age-related macular degeneration.
Burgos-Blasco B; Güemes-Villahoz N; Hernández-Ruiz S; Donate-Lopez J; López-Guajardo L
Arch Soc Esp Oftalmol (Engl Ed); 2022 Dec; 97(12):676-683. PubMed ID: 35879177
[TBL] [Abstract][Full Text] [Related]
9. Baseline characteristics and progression of neovascular age-related macular degeneration in patients receiving over 60 intravitreal injections of anti-vascular endothelial growth factor.
Prahs P; Brandl C; Helbig H; Volz C
Rom J Ophthalmol; 2023; 67(3):260-266. PubMed ID: 37876508
[No Abstract] [Full Text] [Related]
10. Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness!
Lestable L; Gabrielle PH; Bron AM; Nguyen P; Creuzot-Garcher C
J Fr Ophtalmol; 2020 Oct; 43(8):761-769. PubMed ID: 32622633
[TBL] [Abstract][Full Text] [Related]
11. Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.
Spielberg L; Leys A
Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):943-56. PubMed ID: 20204659
[TBL] [Abstract][Full Text] [Related]
12. Anatomical effects of intravitreal anti-vascular endothelial growth factor injections on inner layers of the lesion-free retina.
Demir N; Sevincli S; Kayhan B; Sonmez M
Cutan Ocul Toxicol; 2021 Jun; 40(2):135-139. PubMed ID: 33944638
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration in Vulnerable Fellow Eyes: A Randomized Clinical Trial.
Chan CK; Lalezary M; Abraham P; Elman M; Beaulieu WT; Lin SG; Khurana RN; Bansal AS; Wieland MR; Palmer JD; Chang LK; Lujan BJ; Yiu G;
Ophthalmol Retina; 2022 Jun; 6(6):484-494. PubMed ID: 35121216
[TBL] [Abstract][Full Text] [Related]
14. Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration.
Kabanarou SA; Xirou T; Mangouritsas G; Garnavou-Xirou C; Boutouri E; Gkizis I; Chatziralli I
Clin Interv Aging; 2017; 12():911-915. PubMed ID: 28603410
[TBL] [Abstract][Full Text] [Related]
15. Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF Therapy.
Szigiato A; Mohan N; Talcott KE; Mammo DA; Babiuch AS; Kaiser PK; Ehlers JP; Rachitskaya A; Yuan A; Srivastava SK; Sharma S
Ophthalmol Retina; 2024 Jan; 8(1):10-17. PubMed ID: 37673396
[TBL] [Abstract][Full Text] [Related]
16. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems.
Finger RP; Daien V; Eldem BM; Talks JS; Korobelnik JF; Mitchell P; Sakamoto T; Wong TY; Pantiri K; Carrasco J
BMC Ophthalmol; 2020 Jul; 20(1):294. PubMed ID: 32680477
[TBL] [Abstract][Full Text] [Related]
17. Meticulous multimodal analysis of aflibercept therapy for submacular vascularized pigment epithelial detachment associated with neovascular AMD in a prospective case series, the EVEN study.
Chan CK; Sarraf D; Abraham P; Lalezary M; Lin SG; Chen X; Nittala MG; Sadda S
Am J Ophthalmol Case Rep; 2020 Dec; 20():100916. PubMed ID: 33024885
[TBL] [Abstract][Full Text] [Related]
18. Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration.
Eng VA; Rayess N; Nguyen HV; Leng T
PLoS One; 2020; 15(5):e0232353. PubMed ID: 32369500
[TBL] [Abstract][Full Text] [Related]
19. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
[TBL] [Abstract][Full Text] [Related]
20. Non-neovascular fluid in age-related macular degeneration: observe-and-extend regimen in a case-series study.
Santina A; Romero-Morales V; Abraham N; Somisetty S; Fogel-Levin M; Bousquet E; Nudleman E; Sadda S; Sarraf D
Can J Ophthalmol; 2023 Dec; 58(6):592-600. PubMed ID: 36108790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
